Glioma-targeting micelles for optical/magnetic resonance dual-mode imaging

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 1805-1818

  Zhou, Qing ^a   Mu, Ketao ^b   Jiang, Lingyu ^a   Xie, Hui ^c   Liu, Wei ^a   Li, Zhengzheng ^a   Qi, Hui ^a   Liang, Shuyan ^a   Xu, Huibi ^a   Zhu, Yanhong ^a   Zhu, Wenzhen ^b   Yang, Xiangliang ^a  

^a Department of Biomedical Engineering   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c China Patent Information Center   (China)

Author keywords

Fluorescence image; Glioma; Lactoferrin; Micelles; MRI

Indexed keywords

CONTRAST MEDIUM; LACTOFERRIN; POLYCAPROLACTONE; POLYETHYLENE GLYCOL BLOCK POLYCAPROLACTONE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE; UNCLASSIFIED DRUG; CARBOCYANINE; CY5.5 CYANINE DYE; LACTONE; MACROGOL DERIVATIVE; MAGNETITE NANOPARTICLE; MICELLE; POLY(ETHYLENE GLYCOL)-BLOCK-POLY(EPSILON-CAPROLACTONE);

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BIOCOMPATIBILITY; CANCER DIAGNOSIS; CHEMICAL ANALYSIS; CONCENTRATION (PARAMETERS); CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; ENCAPSULATION; FLUORESCENCE IMAGING; GLIOMA; GLIOMA CELL; HYDROPHOBICITY; IMAGE ANALYSIS; IN VIVO STUDY; MICELLE; MOLECULAR IMAGING; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCESS DEVELOPMENT; TISSUE CHARACTERIZATION; TUMOR LOCALIZATION; ANIMAL; CHEMISTRY; METABOLISM; PATHOLOGY; PROCEDURES; RAT; TUMOR CELL LINE;

ANIMALS; CARBOCYANINES; CELL LINE, TUMOR; GLIOMA; LACTONES; MAGNETIC RESONANCE IMAGING; MAGNETITE NANOPARTICLES; MICELLES; OPTICAL IMAGING; POLYETHYLENE GLYCOLS; RATS;

EID: 84924322645     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S72910     Document Type: Article

References (35)

1. Tanaka S, Louis DN, Curry WT, Batchelor TT, Dietrich J. Diagnostic and therapeutic avenues for glioblastoma: no longer a dead end? Nat Rev Clin Oncol. 2013;10(1):14-26.
2. Koo YE, Reddy GR, Bhojani M, et al. Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev. 2006;58(14):1556-1577.
3. Sanai N, Berger MS. Glioma extent of resection and its impact on patient outcome. Neurosurgery. 2008;62(4):753-766.
4. Claes A, Idema AJ, Wesseling P. Diffuse glioma growth: a guerilla war. Acta Neuropathol. 2007;114(5):443-458.
5. Zhou J, Tryggestad E, Wen Z, et al. Differentiation between glioma and radiation necrosis using molecular magnetic resonance imaging of endogenous proteins and peptides. Nat Med. 2011;17(1):130-134.
6. Giesel FL, Mehndiratta A, Essig M. High-relaxivity contrast-enhanced magnetic resonance neuroimaging: a review. Eur Radiol. 2010;20(10):2461-2474.
7. Crich G, Cabella C, Barge A, et al. In vitro and in vivo magnetic resonance detection of tumor cells by targeting glutamine transporters with Gd-based probes. J Med Chem. 2006;49(16):4926-4936.
8. Laurent S, Forge D, Port M, et al. Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev. 2008;108(6):2064-2110.
9. Xu Z, Shen C, Hou Y, Gao H, Sun S. Oleylamine as both reducing agent and stabilizer in a facile synthesis of magnetite nanoparticles. Chem Mater. 2009;21(9):1778-1780.
10. Veiseh O, Sun C, Fang C, et al. Specific targeting of brain tumors with an optical/magnetic resonance imaging nanoprobe across the blood-brain barrier. Cancer Res. 2009;69(15):6200-6207.
11. Ai H, Flask C, Weinberg B, et al. Magnetite-loaded polymeric micelles as ultrasensitive magnetic-resonance probes. Adv Mater. 2005;17(16):1949-1952.
12. Weissleder R, Bogdanov A, Neuwelt EA, Papisov M. Long-circulating iron oxides for MR imaging. Adv Drug Deliv Rev. 1995;16(2):321-334.
13. Cheng D, Hong G, Wang W, et al. Nonclustered magnetite nanoparticle encapsulated biodegradable polymeric micelles with enhanced properties for in vivo tumor imaging. J Mater Chem. 2011;21(13):4796-4804.
14. Kubben PL, ter Meulen KJ, Schijns OE, ter Laak-Poort MP, van Overbeeke JJ, van Santbrink H. Intraoperative MRI-guided resection of glioblastoma multiforme: a systematic review. Lancet Oncol. 2011;12(11):1062-1070.
15. Louie A. Multimodality imaging probes: design and challenges. Chem Rev. 2010;110(5):3146-3195.
16. Yan H, Wang L, Wang J, et al. Two-order targeted brain tumor imaging by using an optical/paramagnetic nanoprobe across the blood-brain barrier. ACS Nano. 2011;6(1):410-420.
17. Tsugu A, Ishizaka H, Mizokami Y, et al. Impact of the combination of 5-aminolevulinic acid-induced fluorescence with intraoperative magnetic resonance imaging-guided surgery for glioma. World Neurosurg. 2011;76(1-2):120-127.
18. Tonn JC, Stummer W. Fluorescence-guided resection of malignant gliomas using 5-aminolevulinic acid: practical use, risks, and pitfalls. Clin Neurosurg. 2007;55:20-26.
19. Floeth FW, Sabel M, Ewelt C, et al. Comparison of 18F-FET PET and 5-ALA fluorescence in cerebral gliomas. Eur J Nucl Med Mol Imaging. 2011;38(4):731-741.
20. Weissleder R, Ntziachristos V. Shedding light onto live molecular targets. Nat Med. 2003;9(1):123-128.
21. Luo S, Zhang E, Su Y, Cheng T, Shi C. A review of NIR dyes in cancer targeting and imaging. Biomaterials. 2011;32(29):7127-7138.
22. Xie H, Zhu Y, Jiang W, et al. Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles as a specific MRI contrast agent for detection of brain glioma in vivo. Biomaterials. 2011;32(2):495-502.
23. Jiang LY, Zhou Q, Mu KT, et al. pH/temperature sensitive magnetic nanogels conjugated with Cy5.5-labled lactoferrin for MR and fluorescence imaging of glioma in rats. Biomaterials. 2013;34(30):7418-7428.
24. Cha EJ, Jang ES, Sun IC, et al. Development of MRI/NIRF ‘activatable’ multimodal imaging probe based on iron oxide nanoparticles. J Control Release. 2011;155(2):152-158.
25. Vahrmeijer AL, Hutteman M, van der Vorst JR, van de Velde CJ, Frangioni JV. Image-guided cancer surgery using near-infrared fluorescence. Nat Rev Clin Oncol. 2013;10(9):507-518.
26. Cho HJ, Yoon HY, Koo H, et al. Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis. J Control Release. 2012;162(1):111-118.
27. Gu H, Zheng R, Zhang X, Xu B. Facile one-pot synthesis of bifunctional heterodimers of nanoparticles: a conjugate of quantum dot and magnetic nanoparticles. J Am Chem Soc. 2004;126(18):5664-5665.
28. Howes P, Green M, Bowers A, et al. Magnetic conjugated polymer nanoparticles as bimodal imaging agents. J Am Chem Soc. 2010;132(28):9833-9842.
29. Kircher MF, Mahmood U, King RS, Weissleder R, Josephson L. A multimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res. 2003;63(23):8122-8125.
30. Bigall NC, Parak WJ, Dorfs D. Fluorescent, magnetic and plasmonic-hybrid multifunctional colloidal nano objects. Nano Today. 2012;7(4):282-296.
31. Demeule M, Currie JC, Bertrand Y, et al. Involvement of the low-density lipoprotein receptor-related protein in the transcytosis of the brain delivery vector angiopep-2. J Neurochem. 2008;106(4):1534-1544.
32. Strickland DK, Gonias SL, Argraves WS. Diverse roles for the LDL receptor family. Trends Endocrinol Metab. 2002;13(2):66-74.
33. Savic R, Luo LB, Eisenberg A, Maysinger D. Cellular distribution of nonionic micelles-response. Science. 2004;303(5658):627-628.
34. Na HB, Song IC, Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater. 2009;21(21):2133-2148.
35. Sun C, Du K, Fang C, et al. PEG-mediated synthesis of highly dispersive multifunctional superparamagnetic nanoparticles: their physicochemical properties and function in vivo. ACS Nano. 2010;4(4):2402-2410.